Full Text View
Tabular View
Study Results
Related Studies
Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen
This study has been completed.
Study NCT00613314   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received on January 31, 2008.   Last Updated on May 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Metabolic Syndrome X
More general conditions related to this trial
Cardiovascular Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Antihypertensive Agents
Telmisartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services